Effect of smoking on disability progression in patients with multiple sclerosis

被引：0
|
作者：
Gunduz, Tuncay [1 ]
Kurtuncu, Murat [1 ]
机构：
[1] Istanbul Univ, Istanbul Fac Med, Dept Neurol, Istanbul, Turkey
来源：
TOBACCO INDUCED DISEASES | 2018年 / 16卷
关键词：
D O I：
10.18332/tid/94763
中图分类号：
R194 [卫生标准、卫生检查、医药管理];
学科分类号：
摘要：
A54
引用
收藏
页码：28 / 28
页数：1
相关论文
共 50 条
  • [21] Smoking and Disease Progression in Multiple Sclerosis
    Healy, Brian C.
    Ali, Eman N.
    Guttmann, Charles R. G.
    Chitnis, Tanuja
    Glanz, Bonnie I.
    Buckle, Guy
    Houtchens, Maria
    Stazzone, Lynn
    Moodie, Jennifer
    Berger, Annika M.
    Duan, Yang
    Bakshi, Rohit
    Khoury, Samia
    Weiner, Howard
    Ascherio, Alberto
    ARCHIVES OF NEUROLOGY, 2009, 66 (07) : 858 - 864
  • [22] Cigarette smoking and the progression of multiple sclerosis
    Hernán, MA
    Jick, SS
    Logroscino, G
    Olek, MJ
    Ascherio, A
    Jick, H
    BRAIN, 2005, 128 : 1461 - 1465
  • [23] Cigarette smoking and progression in multiple sclerosis
    Koch, Marcus
    van Harten, Annemarie
    De Keyser, Jacques
    NEUROLOGY, 2007, 69 (15) : 1515 - 1520
  • [24] Cigarette smoking and progression in multiple sclerosis
    Koch, M. W.
    van Harten, A.
    Uyttenboogaart, M.
    De Keyser, J.
    MULTIPLE SCLEROSIS, 2007, 13 : S88 - S88
  • [25] Effect of ofatumumab treatment on disability progression independent of relapse activity in patients with relapsing multiple sclerosis
    Kappos, L.
    Montalban, X.
    Cohen, J. A.
    Comi, G.
    Coyle, P. K.
    Li, B.
    Sfikas, N.
    Willi, R.
    Haring, D. A.
    Merschhemke, M.
    Hauser, S. L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 47 - 47
  • [26] Effect of natalizumab on brain atrophy and disability progression in multiple sclerosis patients over 5 years
    Zivadinov, R.
    Hojnacki, D.
    Bergsland, N.
    Kennedy, C.
    Hagemeier, J.
    Melia, R.
    Ramasamy, D. P.
    Durfee, J.
    Carl, E.
    Dwyer, M. G.
    Weinstock-Guttman, B.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 (06) : 1101 - 1109
  • [27] Long-term treatment effect over disability progression in patients with relapsing multiple sclerosis
    Casanova Estruch, B.
    Perez-Miralles, F. C.
    Gascon, F.
    Alcala, C.
    Navarre, A.
    Bernat, A.
    Bosca, I.
    Escutia, M.
    Gil-Perotin, S. G.
    Coret, F.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 117 - 118
  • [28] The VEMP score: a promising marker of disability progression in patients with multiple sclerosis
    Gabelic, T.
    Skoric, M. Krbot
    Adamec, I.
    Habek, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 332 - 332
  • [29] Interferon β1a (Avonex®) treatment in multiple sclerosis:: similarity of effect on progression of disability in patients with mild and moderate disability
    Vermersch, R
    de Seze, J
    Stojkovic, T
    Hautecoeur, R
    JOURNAL OF NEUROLOGY, 2002, 249 (02) : 184 - 187
  • [30] Can the VEMP Score Predict a Disability Progression in Patients with Multiple Sclerosis?
    Gabelic, Tereza
    Krbot, Magdalena
    Adamec, Ivan
    Habek, Mario
    NEUROLOGY, 2016, 86
12345